Daré Bioscience, Inc. (DARE)
0.8015
-0.02
(-2.24%)
USD |
NASDAQ |
Aug 24, 16:00
0.8277
+0.03
(+3.27%)
Pre-Market: 09:15
Daré Bioscience Gross Profit Margin (Quarterly) : -294.5% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -294.5% |
| March 31, 2026 | -422.6% |
| December 31, 2025 | 5.74% |
| September 30, 2025 | -26.55K% |
| June 30, 2025 | |
| March 31, 2025 | -1.01K% |
| September 30, 2024 | 76.50% |
| June 30, 2024 | 31.25% |
| March 31, 2024 | -16.13% |
| December 31, 2023 | 99.45% |
| September 30, 2023 | 99.07% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 99.95% |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 |
| Date | Value |
|---|---|
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.00% |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | 0.00% |
| March 31, 2014 | 0.00% |
| December 31, 2013 | -466.7% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Nektar Therapeutics | 98.46% |
| Elite Pharmaceuticals, Inc. | 40.61% |
| Eton Pharmaceuticals, Inc. | 67.61% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -43.46% |
| Return on Invested Capital | -174.9% |
| Profit Margin (Quarterly) | -1.59K% |
| Operating Margin (Quarterly) | -1.58K% |
| Return on Net Operating Assets | -175.5% |